Coverage
-
March 22, 2013
A Missouri judge on Friday rejected a doctor's testimony arguing the contraceptive NuvaRing should be pulled from the market, but refused to exclude future testimony to that effect in the sprawling product liability multidistrict litigation against a Merck & Co. Inc. subsidiary.
7 other articles on this case.
View all »